Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07431528

Dementia and Storytelling in Vietnam

This project aims to improve knowledge regarding Alzheimer's dementia and related dementias (ADRD) among older adults and their caregivers in Vietnam and promote the early diagnosis of ADRD using a digital storytelling intervention.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vietnam National Geriatric Hospital

Hanoi, Vietnam

Location contact

Vu Huyen, MD, PhD

CONTACT

[email protected]

About this study

This study will develop and test a Digital Storytelling intervention to improve older adults' and caregivers' knowledge of ADRD and to facilitate early diagnosis in rural areas of Vietnam. The Digital Storytelling Intervention includes interactive multimedia modules for motivating behavior change and improving knowledge and attitudes toward ADRD among older adults and their caregivers through the power and voices of patients with mild to moderate ADRD, older persons with cognitive concerns, and their caregivers. Mobile Health technology (Computerized Intervention Authoring System - CIAS) will be used to deliver the intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Older adults (age ≥ 60 years) residing in one of the four participating communities (communities in rural areas of Phu Tho province with minimum distance of 10 km between participating communities)
  • Concern about mild cognitive impairment expressed by the participant, caregiver, or healthcare provider, with no formal screening for ADRD
  • Ability and willingness to provide informed consent
  • Caregivers of eligible participants will be invited to participate after providing written consent.

Exclusion criteria

  • Current participation in another ADRD study
  • Severe cognitive impairment as evaluated by study co-investigators
  • Enrollment in palliative care or diagnosis of a terminal illness
  • Previous exposure to digital storytelling modules
  • Prior participation in the digital storytelling development.

Treatment and study plan

Storytelling intervention

Behavioral

Participants will receive a digital storytelling intervention featuring narratives from older adults with mild to moderate Alzheimer's disease and related dementias (ADRD) and their caregivers who have successfully managed the condition. The stories highlight the benefits of early ADRD diagnosis and strategies for managing diagnostic and care-related challenges. The intervention will be delivered at baseline and biweekly thereafter for three months via CIAS, with didactic "Learn More" modules provided following the stories.

Basic information

Behavioral

Participants will receive basic information about Alzheimer's disease and related dementias (ADRD), issued by the Vietnam Ministry of Health (usual care), at baseline and at Month 3.

Primary outcomes

  1. Intervention Feasibility: Participant Recruitment and Retention

    Time frame: Baseline, Month 3, Month 6

    Feasibility will be assessed using recruitment and retention records, including the number of participants approached, reasons for ineligibility or refusal, and study completion rates.

  2. Intervention Engagement: Interaction Records from CIAS

    Time frame: Month 3, Month 6

    Engagement will be assessed using the number of videos watched.

  3. Intervention Engagement: Exit Interview

    Time frame: Month 6

    Information on participants' experiences with the intervention will be collected through exit interviews.

  4. Intervention Acceptability: System Usability Scale (SUS)

    Time frame: Month 3, Month 6

    SUS is a 10-item, 5-point Likert scale for subjective assessment of usability. The SUS scores range from 0 to 100. A score of > 50 indicates that the technology-based interventions are acceptable.

  5. ADRD Knowledge: Dementia Knowledge Assessment Scale (DKAS)

    Time frame: Baseline, Month 3, Month 6

    DKAS is a 25-item scale that evaluates dementia knowledge. Total scores range from 0 to 50, with higher scores indicating greater knowledge.

  6. Attitudes: Dementia Attitude Scale (DAS)

    Time frame: Baseline, Month 3, Month 6

    DAS is a 20-item, 7-point Likert scale assessing attitudes toward dementia and people living with dementia. Items are summed, with selected items reverse-coded as appropriate, to calculate a total score (range: 20-140). Higher scores indicate more positive attitudes.

Secondary outcomes

  1. ADRD Screening/Diagnosis

    Time frame: Month 3, Month 6

    Rates of ADRD screening and diagnosis will be obtained via interviews and through review of participants' medical records by trained study staff. The diagnosis will be reviewed and confirmed by the study co-investigators (physicians).

  2. Quality of Life: SF-12

    Time frame: Baseline, Month 3, Month 6

    The SF-12 is a 12-item scale that assesses health-related quality of life across physical and mental well-being domains. Scores can range from 0 to 100, with higher scores indicating better quality of life.

  3. Self-Care: The Self-Care of Chronic Illness Inventory (SC-CII)

    Time frame: Baseline, Month 3, Month 6

    SC-CII is a 29-item scale assessing self-care behaviors across three domains: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with higher scores indicating better self-care.

Study contacts

Contact information is provided by the study sponsor or research team.

Deogwoon Kim, PhD

CONTACT

[email protected]

Hoa Nguyen, PhD

CONTACT

[email protected]

508-856-8999

Sponsors and collaborators

Lead sponsor

University of Massachusetts, Worcester

Other

Collaborators

  • Alzheimer's Association

Registry information

Official study title

Digital Storytelling to Promote Early Dementia Diagnosis in Rural Vietnam

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 24, 2026
Registry last updated
Feb 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.